company is $0.71 - $2.42. The shares of the company have plunged over 54% in the last one year. The company is a biopharmaceutical company that discovers and develops treatments for patients suffering from pain and immuno-inflammatory diseases.

Referenced Stocks: ASML, BAC, COH, DNDN, FB, NOK, PFE, QQQ, S, SIRI, STX, UBS. The NASDAQ 100 Pre-Market Indicator is up 6.57 to 2648.69.

We previously published our investment research report analyzing Nokia Corporation's (NOK) struggles. Due to the interest that report generated, we followed it up by researching, analyzing and evaluating Nokia's turnaround efforts versus Sprint Nextel ...

Nokia Corporation (NYSE:NOK)'s Board of Directors have authorized today an adjustment to the planned maximum number of stock options it will grant in 2012 under the Nokia Stock Option Plan 2011.

Send Message Add to Contacts. For traders and speculators, stocks at small cap price levels such as Nokia Corporation (NYSE: NOK), Research-in-Motion (NASDAQ: RIMM) and Alcatel-Lucent (NYSE: ALU) offer the opportunity for profits at low entry costs.

Put options have been in heavy rotation on Nokia Corporation (NYSE:NOK - 1.84) over the course of the past week. During this time frame, speculators on the International Securities Exchange (ISE) and Chicago Board Options Exchange (CBOE) have bought ...